# Oncogenesis

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/oncogenesis/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 2157-9024 |
| ISSNs | 2157-9024 |
| OpenAlex ID | https://openalex.org/S4210239318 |
| Publisher | Springer Nature |

## Journal papers

- [The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy](https://scholariq.org/papers/the-crosstalk-between-stat3-and-p53-ras-signaling-controls-cancer-cell/)
- [BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling](https://scholariq.org/papers/bet-protein-inhibitor-jq1-downregulates-chromatin-accessibility-and-suppresses/)
- [MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression](https://scholariq.org/papers/mir-125a-promotes-paclitaxel-sensitivity-in-cervical-cancer-through-altering/)
- [TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer](https://scholariq.org/papers/ttk-promotes-mesenchymal-signaling-via-multiple-mechanisms-in-triple-negative/)
- [Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway](https://scholariq.org/papers/metformin-exhibits-antiproliferation-activity-in-breast-cancer-via-mir-483-3p/)
- [Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions](https://scholariq.org/papers/novel-therapeutic-strategy-for-cervical-cancer-harboring-fgfr3-tacc3-fusions/)
- [Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer](https://scholariq.org/papers/migration-and-invasion-is-inhibited-by-silencing-ror1-and-ror2-in-chemoresistant/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
